CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Twist Bioscience Corporation  (TWST)
Other Ticker:  
 

Twist Bioscience's Long Term Debt to Equity

TWST's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In the third quarter 2024 Twist Bioscience did not have Long Term Debt.

Within Biotechnology & Pharmaceuticals industry Twist Bioscience Corporation achieved the lowest Long Term Debt to Equity in the third quarter 2024. While total ranking remained the same in the third quarter 2024 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt TWST´s has?
What is the structure of TWST´s Equity?


TWST Long Term Debt to Equity (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter
Y / Y Equity Change -25.31 % -20.43 % -20.94 % -21.02 % -19.88 %
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
TWST's Total Ranking # # # # #
Seq. Equity Change -12.32 % -5.07 % -5.36 % -5.19 % -6.59 %
Seq. Long Term Debt Change - - - - -

New: More TWST's historic Long Term Debt to Equity Ratios >>


Long Term Debt to Equity third quarter 2024 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Twist Bioscience's Equity $ 491 Millions Visit TWST's Balance sheet
Twist Bioscience's Long Term Debt $ 0 Millions Visit TWST's Balance sheet
Source of TWST's Sales Visit TWST's Sales by Geography


Cumulative Twist Bioscience's Long Term Debt to Equity

TWST's Long Term Debt to Equity for the trailling 12 Months

TWST Long Term Debt to Equity

 (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter
Y / Y Equity TTM Growth -25.31 % -20.43 % -20.94 % -21.02 % -19.88 %
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth -12.32 % -5.07 % -5.36 % -5.19 % -6.59 %
Seq. Long Term Debt TTM Growth - - - - -

TWST Company Profile >> Back to TWST Financial Strength Comparisons >> Compare TWST Debt to Equity Ratio to its Competitors

On the trailing twelve months basis During the twelve months ending III Quarter 2024 Twist Bioscience did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry TWST recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt TWST´s has?
What is the structure of TWST´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Jun 30 2024, within Biotechnology & Pharmaceuticals Industry Long Term Debt to EquityJun 30 2024 MRQ Long Term DebtJun 30 2024 MRQ Equity

Date modified: 2024-09-07T17:14:13+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com